En poursuivant votre navigation sur ce site, vous acceptez le dépôt de cookies dans votre navigateur. (En savoir plus)
Portail > Offres > Offre UMR5086-PIEFAL-005 - CDD Post-doctoral H/F 24 mois Biochimie des cibles membranaires d'intérêt thérapeutique

Post-doctoral CDD M/F 24 months Biochemistry of membrane targets of therapeutic interest

This offer is available in the following languages:
Français - Anglais

Date Limite Candidature : vendredi 4 février 2022

Assurez-vous que votre profil candidat soit correctement renseigné avant de postuler. Les informations de votre profil complètent celles associées à chaque candidature. Afin d’augmenter votre visibilité sur notre Portail Emploi et ainsi permettre aux recruteurs de consulter votre profil candidat, vous avez la possibilité de déposer votre CV dans notre CVThèque en un clic !

Faites connaître cette offre !

General information

Reference : UMR5086-PIEFAL-005
Workplace : LYON 07
Date of publication : Friday, January 14, 2022
Type of Contract : FTC Scientist
Contract Period : 24 months
Expected date of employment : 30 March 2022
Proportion of work : Full time
Remuneration : 31965€/year
Desired level of education : PhD
Experience required : 1 to 4 years

Missions

The candidate will be responsible for the expression, extraction, purification and stabilization of human and fungal membrane targets of the type receptor, pump, channel, etc... for their biochemical characterization for therapeutic purposes

Activities

Expression of membrane proteins in yeast and human cells
Extraction of these proteins
Purification of these proteins
Stabilization of these proteins
Biochemical characterization (function, binding) of these proteins

Skills

Required: In-depth knowledge of expression, extraction, purification and stabilization of membrane targets.

Work Context

The post-doc will be carried out in partnership between the "Drug Resistance and Membrane Proteins" team of MMSB and the company Calixar, within the framework of the France-Relance plan. The activities will be divided between the two laboratories, both located in Lyon

Constraints and risks

none

Additional Information

CDD in frame of the ANR France Relance AAP, to boost the industry

We talk about it on Twitter!